AMR Software
AMR Data Centers

Materialise CEO Calls for Improved Clinical Measurement Standards to Help Expand Medical 3D Printing

Share this Article

3dp_Materialise_logoThere’s no denying that 3D printing technology is steadily changing the shape of the medical industry, whether it be through anatomical models, guides, implants, or the many other applications that continue to become more widely accepted and used in healthcare services across the world. One of the top providers of the healthcare-driven 3D printing revolution is the Leuven, Belgium-based Materialise NV. Focused on academia, medical device companies, and the hospital environment, Materialise has gained quite a stronghold on the medical industry over the past few years.

Last year, we covered the service bureau’s partnership with medical product development company Kapstone Medical, as well as a five-year deal with Japan’s Medical Dynamic Marketing, Inc., who partnered with Materialise for 3D printed hip replacements. Their biomedical software, called the Mimics Innovation Suite, is respected across the industry for its quality patient-specific 3D modeling capabilities. Just recently, Mimics proved itself ready-and-able to help provide successful thyroplasty surgery to trans women , and has also just become the go-to 3D modeling software for the Japan-based healthcare provider Canon Lifecare Solutions.

3d-printed_models

3D printed medical models from Materialise

So it seems safe to say that Materialise is the proper leader for creating more generally accepted measurement standards for medical-based 3D printing, and their CEO, Fried Vancraen, is calling for an experienced initiative to develop this tightened approach. With a globally accepted set of guidelines, the medical 3D printing industry can better persuade physicians, hospitals, and policy makers to adopt this increasingly valuable technology. With a developed set of clinical measurement standards for the medical use of 3D printing, government bodies and insurance companies are also more likely to add medical 3D printing to their approved list of medical procedures and devices, which will allow patients access to the most modern, technologically-driven healthcare solutions.

“There have been several initiatives aimed at properly measuring and validating the clinical benefits of medical 3D Printing, but all have suffered from a lack of coordination and agreed-upon research methodologies,” Vancraen stated. “The fact is, we can only be successful if we take an evidence-based approach across the industry, acting in concert with a set of protocols, methodologies and measurement guidelines. With the proper scientific rigor, our ambition of gaining widespread acceptance of medical 3D Printing will be realized more swiftly, and the patients whom we aim to serve will benefit the most.”

Materialise CEO Fried Vancraen

Materialise CEO Fried Vancraen

To help jumpstart the initiative, Materialise will lead the way by studying and designing an evidence-based approach to create these clinical standards, which will include an economical, clinical, engineering and patient-based focus. According to Vancraen, Materialise’s goal is to set the groundwork for more solid measurements, which will help validate a variety of medically-driven 3D printing applications, including anatomical models, patient-specific guides, and implants. With these plans, Materialise can help ingrain 3D printing technology even more deeply into the medical industry by producing more solid clinical evidence, which should further incline physicians, hospitals, and other medical organizations to implement 3D printing into their own healthcare services.

Materialise will be presenting this on-going initiative at Building Evidence for 3D Printing Applications in Medicine, an event hosted by SME and sponsored by Materialise. This event will follow the RAPID Conference, an annual 3D printing conference that will take place at the Orange County Convention Center in Orlando, Florida from May 19-20. If you’d like to learn more about this well-rounded approach to creating better clinical measurement standards for 3D printing, you can either register for the upcoming event or—for those not in the vicinity of the in-person discussion—request more information from the Materialise website. Discuss in the Materialise 3D Printing and Clinical Evidence forum over at 3DPB.com.

[Source: Materialise NV via Ortho Spine News]

 



Share this Article


Recent News

3D Printing News Briefs, May 17, 2025: Color-Changing Materials, Humanoid Robot, & More

Stratasys Acquires Forward AM’s Operations and Assets, Launches Mass Additive Manufacturing



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Featured

Disruption, as Usual: Rich Garrity on How Stratasys Plans to Capitalize on 3D Printing’s Latest Big Opportunity

Few companies in the history of additive manufacturing (AM) have had as much impact as Stratasys on the overall course of the industry’s development. Stratasys has existed for about as...

3D Printing Financials: Stratasys Kicks Off 2025 with Fresh Cash and a Tight Grip on Strategy

Stratasys (Nasdaq: SSYS) started the year with strong momentum, adding fresh cash to its balance sheet and achieving profitability on an adjusted basis. The company also gained a new investor,...

Stifel’s AM Forward Fund Launches, Looking for US Manufacturers to Invest In

The need for greater resiliency in the defense supply chain is real and urgent. One area the US government has been focusing on is building a faster and more sustainable...

Driving Sustainable Additive Manufacturing: Continuum Powders Joins AMGTA as Principal Member

Texas and California-based Continuum Powders, a leading supplier of high-performance, sustainable metal powders for additive manufacturing (AM), is further strengthening its commitment to sustainability and circular manufacturing by joining the...